Standard BioTools Inc.
LAB | NASDAQ
$0.74
-$0.03 (-3.87%)
At close: Sep 21, 2026, 4:00 PM ET
$0.73
-$0.01 (-1.35%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 20.1M | 21.15M | 23.8M | 19.55M | 21.76M | 20.22M | 46.72M | 44.97M | 22.49M | 45.54M | 28.19M | 25.37M | 27.67M | 25.12M | 27.02M | 25.65M | 18.78M | 26.5M | 38.27M | 28.5M | 31.02M | 32.79M |
Cost of Revenue | 9.57M | 9.84M | 13.56M | 10.07M | 11.13M | 9.17M | 24.81M | 21.71M | 12.12M | 21.35M | 14.83M | 14.21M | 14.06M | 12.84M | 15.85M | 16.43M | 14.35M | 14.27M | 18.02M | 14.84M | 14.6M | 13.75M |
Gross Profit | 10.54M | 11.31M | 10.24M | 9.48M | 10.63M | 11.05M | 21.91M | 23.26M | 10.37M | 24.19M | 13.36M | 11.15M | 13.6M | 12.28M | 11.17M | 9.22M | 4.43M | 12.24M | 20.24M | 13.67M | 16.42M | 19.04M |
Operating Income | -25.39M | -9.42M | -21.92M | -23.47M | -23.7M | -24.22M | -32.82M | -31.72M | -30.26M | -60.18M | -21.39M | -21.17M | -17.45M | -16.59M | -21.11M | -29.03M | -38.56M | -27.5M | -11.26M | -19.61M | -17.27M | -19.32M |
Interest Income | n/a | 3.51M | 1.66M | 2.14M | 2.46M | 2.91M | n/a | 3.94M | 5.3M | 6.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -21.44M | -14.62M | -22.03M | -32.9M | -18.28M | -23.49M | -33.8M | -26.82M | -25.41M | -32.03M | -19.94M | -20.95M | -16.74M | -16.58M | -20.78M | -30.14M | -65.15M | -76.86M | -10.24M | -15.27M | -17.66M | -20.49M |
Net Income | -26.76M | -45.22M | 19.28M | -34.69M | -33.46M | -26.03M | -34.07M | -26.94M | -45.72M | -32.16M | -19.78M | -21M | -17.04M | -16.84M | -20.85M | -29.43M | -63.54M | -76.29M | -9.43M | -13.84M | -17.14M | -18.82M |
Selling & General & Admin | 16.39M | 18.61M | 24.38M | 26.6M | 28.11M | 29.82M | 37.59M | 34.4M | 24.86M | 46.94M | 21.35M | 22.29M | 22.6M | 21.3M | 23.9M | 26.34M | 30.08M | 30.88M | 22.96M | 24.07M | 24.25M | 27.61M |
Research & Development | 1.98M | 2.12M | 7.79M | 6.36M | 6.22M | 5.44M | 14.05M | 13.16M | 7.24M | 15.98M | 6.91M | 6.37M | 6.18M | 6.43M | 8.38M | 8.49M | 12.61M | 8.87M | 8.54M | 9.21M | 9.44M | 10.75M |
Other Expenses | 17.56M | n/a | n/a | n/a | n/a | n/a | 3.08M | 7.42M | 8.53M | 21.45M | 6.48M | 3.66M | 2.27M | 1.15M | n/a | 3.42M | 300K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 35.92M | 20.72M | 32.16M | 32.95M | 34.33M | 35.26M | 54.72M | 54.98M | 40.64M | 84.37M | 34.74M | 32.33M | 31.05M | 28.87M | 32.28M | 38.25M | 42.99M | 39.74M | 31.5M | 33.28M | 33.69M | 38.36M |
Interest Expense | n/a | n/a | 5K | 10K | 9K | 2K | n/a | n/a | 858K | 1.03M | 1.1M | 1.22M | 1.13M | 1.12M | 1.19M | 1.05M | 1.06M | 1.03M | 1.07M | 968K | 896K | 887K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 45.49M | 30.56M | 45.72M | 43.02M | 45.46M | 44.44M | 79.54M | 76.69M | 52.75M | 105.72M | 49.57M | 46.54M | 45.12M | 41.71M | 48.13M | 54.67M | 57.34M | 54.01M | 49.52M | 48.12M | 48.29M | 52.11M |
Income Tax Expense | 90K | 11K | -35.93M | -1.22M | -609K | -119K | 272K | 118K | 39K | 128K | -162K | 50K | 301K | 263K | 70K | -713K | -1.61M | -574K | -814K | -1.42M | -517K | -1.67M |
Shares Outstanding (Basic) | 390.88M | 388.2M | 385.05M | 382.63M | 380.5M | 378.23M | 374.54M | 371.54M | 372.33M | 294.13M | 79.73M | 79.15M | 78.67M | 79.08M | 79.43M | 78.9M | 77.82M | 77.03M | 76.65M | 76.3M | 75.45M | 74.71M |
Shares Outstanding (Diluted) | 390.88M | 388.2M | 385.05M | 382.63M | 380.5M | 378.23M | 374.54M | 371.54M | 372.33M | 294.13M | 79.73M | 79.15M | 78.67M | 79.08M | 79.43M | 78.9M | 77.82M | 77.03M | 76.65M | 76.3M | 75.45M | 74.71M |
EPS (Basic) | -0.07 | -0.12 | 0.05 | -0.09 | -0.09 | -0.07 | -0.09 | -0.07 | -0.12 | -0.27 | -0.25 | -0.27 | -0.22 | -0.21 | -0.26 | -0.37 | -0.82 | -0.99 | -0.12 | -0.18 | -0.23 | -0.25 |
EPS (Diluted) | -0.07 | -0.12 | 0.05 | -0.09 | -0.09 | -0.07 | -0.09 | -0.07 | -0.12 | -0.27 | -0.25 | -0.27 | -0.22 | -0.21 | -0.26 | -0.37 | -0.82 | -0.99 | -0.12 | -0.18 | -0.23 | -0.25 |
EBITDA | -26.66M | -13.21M | -20.74M | -31.29M | -16.27M | -19.32M | -26.02M | -20.44M | -20.69M | -25.8M | -14.93M | -13.52M | -11.56M | -11.78M | -15.97M | -25.49M | -60.26M | -71.86M | -5.29M | -10.43M | -12.87M | -15.69M |
EBIT | -29.34M | -14.62M | -22.03M | -32.89M | -18.27M | -23.49M | -29.98M | -24.3M | -24.55M | -31M | -18.84M | -17.51M | -15.18M | -15.44M | -19.59M | -29.09M | -64.09M | -75.83M | -9.17M | -14.3M | -16.76M | -19.61M |
Depreciation & Amortization | 2.68M | 1.41M | 1.29M | 1.6M | 2M | 4.17M | 3.95M | 3.86M | 3.86M | 5.19M | 3.91M | 3.99M | 3.63M | 3.66M | 3.62M | 3.6M | 3.84M | 3.97M | 3.88M | 3.87M | 3.9M | 3.92M |
Add to Watchlist
Select watchlists to add or remove LAB